The benefits of insulin therapy following acute myocardial infarction revisited.
Soran
H
H
Specialist Registrar in Endocrinology and Diabetes, Department of Diabetes & Endocrinology, South Manchester University Hospital, Manchester. hsoran@aol.com
Barzangy
B
B
Younis
N
N
D001786:Blood Glucose; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D003925:Diabetic Angiopathies / Q000150:complications / Q000188:drug therapy*; D004338:Drug Combinations; D005060:Europe; D005947:Glucose / Q000008:administration & dosage; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007328:Insulin / Q000008:administration & dosage*; D015337:Multicenter Studies as Topic; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D013549:Sweetening Agents / Q000008:administration & dosage; D016896:Treatment Outcome
D001786:Blood Glucose; D004338:Drug Combinations; D007004:Hypoglycemic Agents; D007328:Insulin; D013549:Sweetening Agents; D005947:Glucose